Medtech Goes to Capitol Hill
AdvaMed’s annual Medtech Showcase and Reception on Capitol Hill seeks to inform a core audience: the members of the Congress and their staff who enact the policies that help our…
Radiation Therapy
Learn more about our Radiation Therapy work.
Carbon Medical Technologies’ BiomarC Tissue Marker Line Achieves EU MDR Certification
April 25, 2025 – Carbon Medical Technologies, Inc. (CMT), a manufacturer of pyrolytic carbon-coated medical devices used in biopsy procedures, for radiation therapy, and to treat stress urinary incontinence, is…
Accuray President and CEO Suzanne Winter to Head AdvaMed® Radiation Therapy Sector
Today, AdvaMed®, the Medtech Association, announced Suzanne Winter, President and CEO of Accuray, a leading manufacturer of life-saving radiotherapy systems, will head the organization’s radiation therapy (RT) sector. In this…
AdvaMed®’s Whitaker: Cuts to Radiotherapy Fail to Weigh Overwhelming Lifesaving Benefits
Today, AdvaMed®, the Medtech Association, responded to the Centers for Medicare and Medicaid Services’ recently announced Physician Fee Schedule proposed rule, which includes an additional two percent cut to reimbursements for radiation…
New Poll Finds Strong Support for Radiation Therapy in War Against Cancer
Today, AdvaMed®, the MedTech Association, released the findings of a new national poll on radiation therapy and cancer treatment revealing broad support for greater federal investment in the proven cancer…
AdvaMed® Statement on Biden’s Cancer Moonshot Commitment
The Advanced Medical Technology Association® (AdvaMed®), the largest trade association representing medical device manufacturers, including all major radiation therapy manufacturers in the U.S. and abroad. released the following statement from…
AdvaMed® Comments on Proposed Delay of Radiation Oncology Model
AdvaMed® submitted comments to the Center for Medicare and Medicaid Services (CMS) on its Radiation Oncology (RO) Model proposed rule proposing to indefinitely delay the start date of the RO…
Infusing Equity Into the Diagnosis and Treatment of Cancer
For National Minority Cancer Awareness Month, AdvaMed®’s DeChane Dorsey reflects on the continued need for improvements in health equity and the impact of cancer on racial and ethnic minority groups.
Medtech Poised to Make Significant Contribution to White House Cancer Moonshot
Chairman and CEO of Edwards Lifesciences, Mike Mussallem joins AdvaMed®’s Scott Whitaker to discuss the dedication of those in the industry and how policy reform can help speed up the…
AdvaMed® Commends White House on Relaunch of Cancer Moonshot
In a letter to President Joe Biden today, AdvaMed® President and CEO Scott Whitaker thanked the Administration for relaunching the Cancer Moonshot with an emphasis on cancer screening and advances…